<code id='E3D780D7DD'></code><style id='E3D780D7DD'></style>
    • <acronym id='E3D780D7DD'></acronym>
      <center id='E3D780D7DD'><center id='E3D780D7DD'><tfoot id='E3D780D7DD'></tfoot></center><abbr id='E3D780D7DD'><dir id='E3D780D7DD'><tfoot id='E3D780D7DD'></tfoot><noframes id='E3D780D7DD'>

    • <optgroup id='E3D780D7DD'><strike id='E3D780D7DD'><sup id='E3D780D7DD'></sup></strike><code id='E3D780D7DD'></code></optgroup>
        1. <b id='E3D780D7DD'><label id='E3D780D7DD'><select id='E3D780D7DD'><dt id='E3D780D7DD'><span id='E3D780D7DD'></span></dt></select></label></b><u id='E3D780D7DD'></u>
          <i id='E3D780D7DD'><strike id='E3D780D7DD'><tt id='E3D780D7DD'><pre id='E3D780D7DD'></pre></tt></strike></i>

          Home / entertainment / Wikipedia

          Wikipedia


          Wikipedia

          author:comprehensive    Page View:2634
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In